[Sepsis: a conception in change. Possibilities and limitations of diagnosis based on clinical criteria].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to K Reinhart.
Explore the source record for details and available documents.
OBJECTIVES: To test whether dopamine infusion improves oxygen delivery (Do2) and oxygen uptake (VO2) in hyperdynamic septic shock patients stabilized by adequate volume and dobutamine alone, or by the combination of dobutamine and norepinephrine. DESIGN: Prospective clinical trial of two patient groups. Group 1 (n = 15) was stabilized with dobutamine, and group 2 (n = 10) was stabilized with dobutamine and norepinephrine. SETTING: Intensive care unit in a university hospital. PATIENTS: Twenty-five postoperative, hyperdynamic septic shock patients. INTERVENTIONS: The stabilizing catecholamine infusion was replaced in a stepwise manner by dopamine to achieve a similar mean arterial pressure (dopamine doses: group 1, mean 22 +/- 15 micrograms/kg/min [range 6 to 52]; and group 2, mean 57 +/- 41 micrograms/kg/min [range 15 to 130]). MEASUREMENTS AND MAIN RESULTS: A complete hemodynamic profile was performed with oxygen transport-related variables at baseline, after replacement by dopamine, and after resetting to the original catecholamine infusion. The change to dopamine resulted in increases in cardiac index (group 1: 20% [p < .01]; group 2: 33% [p < .01]), and DO2 (group 1: 19% [p < .01]; group 2: 27% [p < .01]). However, VO2, whether directly measured from the respiratory gases or calculated by the cardiovascular Fick principle, did not change in both groups with dopamine, while the oxygen extraction ratio decreased significantly in both groups with dopamine. Heart rate, pulmonary artery occlusion pressure, and pulmonary shunt fraction all increased with dopamine. PaO2 decreased, but oxygen saturation remained stable in both groups with dopamine. CONCLUSIONS: Short-term dopamine infusion in hyperdynamic septic shock patients, despite producing higher global DO2, was not superior to dobutamine or the combination of dobutamine and norepinephrine infusion.
Multiple organ failure is the major cause of death in patients with sepsis. Bacterial translocation from the gut is considered to induce and maintain sepsis. Therefore, the splanchnic region plays an important role in the pathogenesis and treatment of sepsis. There is evidence for a very high risk of imbalance between oxygen delivery and oxygen consumption especially in the splanchnic region. Consequently, there is a crucial interest whether it is possible to influence the splanchnic perfusion by specific catecholamines. Unfortunately, only a few, conflicting studies have looked at the effects of the various catecholamines on regional blood flow. Therefore, a clear recommendation for a specific catecholamine regimen in septic shock is impossible. Furthermore, it is unknown whether the choice of a specific catecholamine in the treatment of septic shock affects the patient's outcome. In most patients, the use of vasopressors is indispensable because adequate haemodynamic perfusion pressure is not achieved with fluid therapy alone. The negative effects of vasopressors on splanchnic perfusion are known from studies carried out under non septic conditions. Norepinephrine and dopamine in doses of 10 micrograms/kg/min in septic animals are without negative effects on splanchnic perfusion. Preliminary results show Preliminary results show a decrease in splanchnic oxygenation in patients with septic shock treated with epinephrine. Catecholamines with beta mimetic effects are often used to increase DO2. The question as to whether dobutamine or dopamine should be used first in treatment of septic shock cannot be answered yet. Whether treatment with low dose dopamine or dopexamine actually improves renal function and splanchnic oxygenation is the purpose of ongoing studies.
Explore the source record for details and available documents.
Hyperoxic ventilation, used to prevent hypoxemia during potential periods of hypoventilation, has been reported to paradoxically decrease whole body oxygen consumption (VO2). Reduction in nutritive blood flow due to oxygen radical production is one possible mechanism. We investigated whether pretreatment with the sulfhydryl group donor and O2 radical scavenger N-acetylcysteine (NAC) would preserve whole body VO2 and prevent deterioration of oxygenation in gastric mucosal tissue during hyperoxia. Thirty-eight patients, requiring hemodynamic monitoring (radial and pulmonary artery catheters) due to sepsis syndrome, were included in this randomized experiment. All patients exhibited stable clinical conditions (hemodynamics, body temperature, hemoglobin, FIO2 < 0.5). A gastric tonometer was placed to measure the gastric intramucosal pH (pHi), which indirectly assesses nutritive blood flow to the mucosa. Cardiac output was determined by thermodilution and VO2 by cardiovascular Fick. After baseline measurements, patients randomly received either 150 mg.kg-1 NAC (n = 19) or placebo (n = 19) in 250 ml 5% dextrose intravenously over a period of 15 min. Measurements were repeated 30 min after starting NAC or placebo infusion, 30 min after starting hyperoxia (FIO2 = 1.0), and 60 min after resetting the original FIO2. There were no significant differences between groups in any of the measurements before treatment and after the return to baseline FIO2 at the end of the study. NAC, but not placebo infusion, caused a slight but significant increase in cardiac output and decrease in systemic vascular resistance.(ABSTRACT TRUNCATED AT 250 WORDS)
Explore the source record for details and available documents.
Explore the source record for details and available documents.
It was the purpose of this study to measure the relationship between hepatic venous O2 saturation (ShvO2) and mixed venous O2 saturation (SvO2) in septic patients (n = 21) following treatment with various catecholamines (epinephrine, norepinephrine, dopamine, dopexamine). At baseline mean SvO2 was 74 +/- 5% while mean ShvO2 was 59 +/- 12%. Alpha-mimetic substances such as epinephrine and norepinephrine reduced ShvO2 and increased the difference between SvO2 and ShvO2.Beta2-mimetic and dopaminergic substances (dopexamine, dopamine) did not change the difference between SvO2 and ShvO2. These results show that SvO2 does not necessarily reflect all changes of ShvO2. Monitoring ShvO2 may be helpful in managing septic shock by adding information on adequacy of O2 supply/consumption ratio in the crucial splanchnic region.
Septic shock and ARDS are associated with disturbed tissue oxygenation. It has been suggested to increase O2 supply (DO2) above the normal level (> 600 ml/min/m2) to compensate for the tissue hypoxia. The lack of a rise in O2 consumption (VO2) after increases of DO2 has been presumed to indicate adequate tissue oxygenation (negative O2 flux test). We were interested in whether a negative O2 flux test precludes an improvement of regional tissue oxygenation. The pH value of the gastric mucosa (pHi) is considered to be a sensitive marker for hypoxia in the splanchnic region. We measured pHi as well as DO2 and VO2 in 10 patients with hyperdynamic septic shock to assess the effect of volume substitution on tissue oxygenation. The initial therapeutic approach (volume substitution and catecholamines) led to a DO2 of 717 +/- 187 ml/min/m2. However, all patients had pHi values < 7.35 indicating regional tissue hypoxia. An additional increase of DO2 by colloidal volume substitution caused a significant rise of pHi from 7.20 +/- 0.05 to 7.25 +/- 0.05 but did not change VO2. We conclude that a negative O2 flux test does not rule out regional tissue hypoxia, and second, an increase in DO2 may improve tissue oxygenation without measurable changes in VO2. Furthermore, adequate volume substitution is an important step in the treatment of septic shock to increase total body blood flow and more specifically regional blood flow.
OBJECTIVE: Investigation of the hypothesis that the infusion of 10 ng/kg/min prostacyclin (epoprostenol) (PGI2) improves O2 uptake in patients with hyperdynamic septic shock. DESIGN: Prospective, single cohort design. SETTING: ICU, university hospital. PATIENTS: Fifteen postoperative patients with septic shock. INTERVENTIONS: Infusion of 10 ng/kg/min of PGI2 for 60 min. MEASUREMENTS: Complete hemodynamic profile with O2 transport-related variables (simultaneous measurements of VO2 from the respiratory gases and by cardiovascular Fick) and blood lactate levels before start of the PGI2-infusion and 60 min thereafter. MAIN RESULTS: Oxygen delivery increased significantly (14 percent) from its already high value, 750 +/- 238 to 852 +/- 214 ml/min/m2. The O2 extraction ratio remained unchanged. When VO2 was measured from the respiratory gases, it was unchanged. When VO2 was measured by cardiovascular Fick, it increased slightly (p < 0.05). CONCLUSIONS: We conclude that in this O2 challenge test with PGI2 in patients with septic shock, an increase in O2 delivery was not matched by an increase in VO2. We believe that the adequate conventional support of these patients may have prevented the PGI2 from revealing a "covert" O2 debt. The PGI2 test did not predict mortality by O2 supply dependency. The small increase in VO2 as calculated indirectly suggests a degree of mathematical coupling of O2 delivery and uptake.
OBJECTIVES: Deactivation of endothelium-derived relaxing factor due to an increased oxygen radical load during sepsis may contribute to an impairment in microcirculatory blood flow. We investigated whether treatment with the sulfhydryl donor and oxygen radical scavenger, N-acetylcysteine, would improve whole-body oxygen consumption (VO2), gastric intramucosal pH, and veno-arterial CO2 gradient (veno-arterial PCO2) during septic shock. DESIGN: Prospective, randomized, double-blind study conducted over 2 yrs. SETTING: Septic shock patients admitted to the intensive care unit. PATIENTS: Fifty-eight patients requiring hemodynamic monitoring (radial and pulmonary artery catheters) due to septic shock, were included in this study. All patients were examined within 72 hrs after the onset of sepsis. They were optimally resuscitated by conventional means with volume and inotropic agents, and exhibited stable clinical conditions (hemodynamic values, body temperature, hemoglobin, FIO2). INTERVENTIONS: A gastric tonometer was inserted to measure the gastric intramucosal pH. Subjects randomly received either 150 mg/kg of intravenous N-acetylcysteine or placebo over a 15-min period, then a continuous infusion of 12.5 mg/hr of N-acetylcysteine or placebo over approximately 90 mins. MEASUREMENTS: Infusion measurements were begun 60 mins after the beginning of infusion and lasted approximately 30 mins. The infusion was then discontinued and 2 hrs later the final measurements were taken. MAIN RESULTS: Basic patient characteristics (age, sex, Acute Physiology and Chronic Health Evaluation [APACHE] II scores, Multiple Organ Failure scores) did not differ significantly, nor did pre- and 2-hr postinfusion measurements differ between any of the groups. Thirteen (45%) patients responded (i.e., showed an increase in VO2 > 10%, reaching a mean of 19%) to the N-acetylcysteine infusion. The N-acetylcysteine responders also showed an increase in gastric intramucosal pH, a decrease in veno-arterial PCO2, an increase in oxygen delivery, cardiac index, stroke index, and left ventricular stroke work index, as well as a significant decrease in systemic vascular resistance in comparison to baseline. The N-acetylcysteine nonresponders, as well as the patients in the placebo group, did not show any significant changes in any of these variables. The N-acetylcysteine responders had a higher survival rate (69%) than the non-responders (19%) and were studied earlier after onset of sepsis (37 hrs) than the nonresponders (61 hrs). The only significant difference between the entire N-acetylcysteine group (which included responders plus nonresponders) and the placebo group was an increased VO2 in the entire N-acetylcysteine group during infusion measurements. CONCLUSIONS: N-acetylcysteine provided a transient improvement in tissue oxygenation in about half of the septic shock patients, as indicated by an increase in VO2 and gastric intramucosal pH and a decrease in veno-arterial PCO2. The higher survival rate in the N-acetylcysteine responders and the fact that half of the patients receiving N-acetylcysteine did not respond, suggests that, in some patients, sepsis irreversibly damages the microvasculature to the extent that N-acetylcysteine has no effect. If analyzed by intention to treat, the N-acetylcysteine did not produce effects that were significantly different from the placebo. Whether the N-acetylcysteine challenge was merely diagnostic or whether N-acetylcysteine can be effective in the treatment of sepsis deserves further investigation.
The significance of the gastrointestinal region in the genesis and course of sepsis makes the monitoring of this region a fundamental importance in critical ill patients. The low-invasive assessment of gastric mucosal pH (pHi) seems to be able to detect a disturbed tissue oxygenation in the splanchnic region at an early stage. Animal studies have shown that there is a good correlation between pHi and directly measured pH. Splanchnic tissue hypoxia, induced in an experimental setting, is detectable by the pHi method. It has been shown in clinical studies that the patients' outcome depends on the first pHi, measured on admission to the ICU. An initial study has shown that patients with a pHi in the normal range on admission to the ICU had a better outcome if they were treated by a pHi-value orientated therapy. Nevertheless, some questions remain: There are problems with the practical use of this method, and it is unclear whether the pHi is really a marker for the whole splanchnic area. Further studies are required to determine the status of pHi in the clinical setting.
The use of small volumes of hypertonic saline (HTS) 7.2-7.5% (small volume resuscitation) in combination with colloidal solutions has been proved to be of value in stabilizing oxygen transport in hemorrhagic shock. The specific effects of HTS lead to an improvement in tissue oxygenation by increasing the cardiac preload, decreasing the afterload and endothelial and interstitial edema within the microcirculation. This study investigates whether the use of HTS combined with hydroxyethylstarch (HAES) leads to a significant increase in the O2 delivery (DO2) and O2 consumption (VO2) in hyperdynamic critically ill patients. A total of 41 patients, 20 septic patients and 21 patients without sepsis were investigated. When a hyperdynamic circulation (DO2 > 700 ml/min/m2) was attained, 2-4 ml/kg 7.5% HTS in 6% HAES were infused over 15 minutes. In the septic patients this leads to a significant increase in the DO2 of 14% (p < 0.001). The VO2 (calculated from the cardiovascular Fick) increased by 7% (p < 0.05). The VO2 calculated from the respiratory gases increased by 4% (n.s.). This < 10% increase in VO2 does not seem to be due to a relevant tissue oxygen debt. This is supported by the fact that in the non septic group the DO2 and VO2 increased by the same extent, there was no significant difference between the two groups. Further there was an equal increase in the O2 extraction ratio of 10% (septic patients) and 9.5% (non septic patients). In both groups the mean plasma lactate levels before and 90 min after the HTS/HAES infusion were within normal range so that a wash-out phenomenon was not discernible.(ABSTRACT TRUNCATED AT 250 WORDS)
The task of the cardiorespiratory system is to deliver enough oxygen to meet the metabolic requirements of the body. Of all metabolic substrates, oxygen has the highest percentage of extraction and oxygen reserves are exhausted within a few minutes. Arterial oxygen content and cardiac output are the determinants of oxygen delivery (DO2). O2-delivery in intensive care patients can be compromised by many factors, especially diminished O2-uptake in the lung, reduced hemoglobin content, and/or altered cardiac performance. To calculate DO2, determination of cardiac output (CO), O2-tension, O2-saturation, and hemoglobin is necessary. O2-consumption (VO2), the best mirror of the actual global metabolic activities of the tissues, can be measured invasively using arterial-venous O2-content difference (avDO2) and cardiac output, which requires pulmonary artery catheterization. The body has two basic mechanisms to meet increased VO2 or to compensate for a decrease in DO2: an increase in CO and a rise in O2-extraction ratio. The avDO2 and O2-extraction ratio are known to be very good indicators for the adaptation of the cardiorespiratory system to the actual metabolic requirements of the body. The oxygen supply-to-demand ratio (DO2/VO2) yields information on the extent to which these compensatory mechanisms either function or fail. It was demonstrated that changes of the avDO2 and changes of the DO2/VO2 are always paralleled unidirectionally by changes of mixed venous O2-saturation (SvO2). Therefore these parameters can easily be replaced by SvO2 for clinical purposes. Continuous real time in-vivo control of SvO2 has now become possible using commercially available devices with fiberoptic catheters. Pathophysiological changes in the O2-supply-to-demand-ratio as well as effects of ongoing therapy can be determined at the bedside.
Due to the complications associated with the incorrect placement of a central venous pressure (cvp) catheter, the correct positioning of a cvp catheter must be controlled. The widespread standard in many hospitals is to carry out a chest x-ray (cxr) following the infusion of a contrast medium through the catheter tip. Together with a recent publication and our experience we would like to introduce a method, which is presently not in widespread use, which enables the exact localization of a catheter tip under ECG control. This technique is simple to apply, reliable and time saving. Furthermore it costs only 20% of the amount required for a radiologically controlled catheter placement. Important for ECG-guided catheter placement control is the availability of an ECG monitor suited for intracardial application and the patients heart rate must be in sinus rhythm.
The lack of a rise in global O2 consumption (VO2) after increased O2 supply (DO2) (negative O2-flux test) is an indication of adequate tissue oxygenation. We were interested in whether a negative O2-flux test precludes an improvement in regional tissue oxygenation. The pH of the gastric mucosa (pHi) is considered a sensitive marker for tissue hypoxia. Method. The study was approved by the ethics committee of our hospital. In 12 intensive-care patients with septic shock, gastric pHi was determined (Trip'TGS catheter, Tonometrics) in addition to measuring O2-transport-related parameters via invasive haemodynamic monitoring. Following the initial measurement, a further increase in the O2 supply via volume substitution was attempted in all already hyperdynamic patients with DO2 in the upper-normal range. Results. Volume substitution with 1.246 +/- 594 ml colloid resulted in an increase in pulmonary capillary wedge pressure from 14 +/- 2 mm Hg to 17 +/- 1 mm Hg (P < 0.01). All patients had an increase in DO2 from 755 +/- 192 ml/min.m2 to 846 +/- 236 ml/min.m2 (P < 0.05). There was no significant change in VO2, at 153 +/- 28 ml/min.m2 before and 156 +/- 35 ml/min.m2 after volume administration. However, pHi increased from 7.19 +/- 0.08 to 7.24 +/- 0.08 (P < 0.01). DISCUSSION AND CONCLUSION. The low pHi at the time of the initial measurement shows that regional tissue hypoxia may be present even in patients with an above-normal O2 supply > 600 ml/min.m2. Apparently, the lack of rise in global O2 consumption after increased O2 supply does not exclude a regional improvement in tissue oxygenation. The less invasive pHi measurement is an additional useful monitoring procedure for the optimisation of regional tissue oxygenation in critically ill patients.
Mixed venous O2-saturation (SvO2) reflects the ratio of global O2 supply to O2 consumption. However, in septic shock, there may be alterations in the ratio of regional O2 supply to O2 consumption, particularly in the splanchnic region. The aim of the study was therefore to investigate the relation between SvO2 and hepaticovenous O2-saturation (ShvO2) in septic shock with different catecholamine regimens. METHOD. Following approval of the ethics commission at our hospital, SvO2 and ShvO2 were measured simultaneously in 29 patients (7.5-F pulmonary arterial catheter). RESULTS. SvO2 and ShvO2 showed a considerable inter-individual difference with values between 1.3 and 36.9% and a mean of 14.7 +/- 9.3%. Alterations of ShvO2 were only tendentially reflected in alterations of the SvO2. Under different catecholamines SvO2 and ShvO2 showed the same changes but varying in extent (Table 1; Fig. 2). After switching the catecholamine therapy from dobutamine to epinephrine, SvO2 decreased only from 76.7 +/- 3.6 to 76.1 +/- 2.3 but ShvO2 from 61.4 +/- 8.1 to 54.2 +/- 10.3%. When the therapy was switched from dobutamine to norepinephrine, SvO2 decreased from 74.8 +/- 4.9% to 68.5 +/- 4.8%, ShvO2 decreased from 61.9 +/- 12.9% to 49.2 +/- 12.8%. When dopamine was added to norepinephrine, SvO2 increased from 68.6 +/- 4.3% to 73.6 +/- 4.4%, ShvO2 increased from 52.6 +/- 12.7% to 63.7 +/- 9.8%. When dopexamine was added to dobutamine, SvO2 increased from 74.6 +/- 4.5% to 76.9 +/- 2.5%, while ShvO2 increased from 57.6 +/- 11.5% to 58.8 +/- 13.4%. DISCUSSION AND CONCLUSION. The results presented show that SvO2 does not provide sufficient information about the venous O2 saturation of the splanchnic region. The intraindividually variable differences between SvO2 and ShvO2 during therapeutic interventions demonstrate that a selective alteration of blood supply to or O2 consumption of the splanchnic region has taken place, which is insufficiently reflected by the SvO2.
We report two boys aged 4 and 10 months who suffered cardiac arrests after induction of anaesthesia. Both infants had no personal or family history of myopathy. In both cases anaesthesia was induced by inhalation with halothane and N2O/O2 (70/30). To facilitate tracheal intubation both were given succinylcholine after the administration of atropine. The 4-month-old developed muscle rigidity and cardiac arrest occurred immediately after tracheal intubation. Resuscitation was unsuccessful. Laboratory findings during resuscitation showed elevated serum potassium levels of more than 10 mmol/l and serum creatine phosphokinase 17.700 IU/l. Histopathologic examination of the skeletal muscle revealed congenital muscular dystrophy. In the older boy no muscle contractures were noted after administration of succinylcholine. He developed bradycardia that progressed to asystole 15 min after induction of anaesthesia. After 1 h of resuscitation a sinus rhythm could be established. The boy developed myoglobinuria and his serum creatine phosphokinase reached a maximum level of 45,000 IU/l on the 2nd day. The child survived and made a complete recovery. Two months later a muscle biopsy taken from the quadriceps showed marked muscular dystrophy. Duchenne's muscular dystrophy could be excluded. The most likely underlying reasons for these complications are discussed: anaesthesia-induced acute rhabdomyolysis or malignant hyperthermia.